“Bayer has been working to improve women’s health in Australia for more than 60 years, and with the PBS listing of YAZ and YASMIN, we are proud to demonstrate this commitment to advancing women’s health by providing solutions for her different reproductive needs," said Manoj Saxena, CEO of Bayer Australia and New Zealand and country division head for the pharmaceutical division
A 'milestone moment' with first oral contraceptive listed on the PBS in over 30 years
March 2, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - -
Island secures USAMRIID partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech -
Cartherics secures Japanese patent to bolster cell therapy push
June 10, 2026 - - Australian Biotech -
GSK to buy Nuvalent in a major move to acquire rights to late stage lung cancer candidates
June 10, 2026 - - Latest News -
Australian company secures US fast track for CAR-T in blood cancers
June 10, 2026 - - Latest News -
Industry campaign highlights MFN risk to US jobs and the broader economy
June 10, 2026 - - Latest News -
New report highlights the potential health-system benefits of pharmacist prescribing
June 9, 2026 - - Latest News

